TY - JOUR
T1 - Role of cytokines in renal osteodystrophy
AU - Monier-Faugere, Marie Claude
AU - Malluche, Hartmut H.
PY - 1997
Y1 - 1997
N2 - Patients with end-stage renal failure present with various debilitating forms of renal osteodystrophy characterized either by high bone turnover with or without mineralization defect or low bone turnover, that is, adynamic bone disease. Alterations in parathyroid hormone and calcitriol production do not completely account for the abnormalities in bone turnover. This suggest that other factors or mediators, or both, are involved in the regulation of bone turnover. Among them, the cytokine systems are of particular interest because of the following: cytokine production is altered in uremic patients; there are interactions between parathyroid hormone, calcitriol, and cytokines; and cytokines modulate bone cell number or activity, or both. Preliminary results of direct assessment of cytokines in bone of uremic patients are promising. Future research in this field should advance our knowledge of the intricate mechanisms that regulate bone turnover in renal osteodystrophy. This could provide a basis for better strategies in the control of bone abnormalities in uremic patients.
AB - Patients with end-stage renal failure present with various debilitating forms of renal osteodystrophy characterized either by high bone turnover with or without mineralization defect or low bone turnover, that is, adynamic bone disease. Alterations in parathyroid hormone and calcitriol production do not completely account for the abnormalities in bone turnover. This suggest that other factors or mediators, or both, are involved in the regulation of bone turnover. Among them, the cytokine systems are of particular interest because of the following: cytokine production is altered in uremic patients; there are interactions between parathyroid hormone, calcitriol, and cytokines; and cytokines modulate bone cell number or activity, or both. Preliminary results of direct assessment of cytokines in bone of uremic patients are promising. Future research in this field should advance our knowledge of the intricate mechanisms that regulate bone turnover in renal osteodystrophy. This could provide a basis for better strategies in the control of bone abnormalities in uremic patients.
UR - http://www.scopus.com/inward/record.url?scp=0030745873&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030745873&partnerID=8YFLogxK
U2 - 10.1097/00041552-199707000-00005
DO - 10.1097/00041552-199707000-00005
M3 - Review article
C2 - 9263681
AN - SCOPUS:0030745873
SN - 1062-4821
VL - 6
SP - 327
EP - 332
JO - Current Opinion in Nephrology and Hypertension
JF - Current Opinion in Nephrology and Hypertension
IS - 4
ER -